PONTELAND MEDICAL GROUP
MEADOWFIELD, PONTELAND, NEWCASTLE UPON TYNE
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 356 | 385 | 92.5% | |
| CKD 4 | 2008 | 435 | 495 | 87.9% | |
| CKD 5 | 2009 | 117 | 138 | 84.8% | |
| CKD 5 | 2010 | 44 | 45 | 97.8% | |
| CKD 5 | 2011 | 41 | 45 | 91.1% | |
| CKD 5 | 2012 | 45 | 51 | 88.2% | |
| CKD 5 | 2013 | 43 | 49 | 87.8% | |
| CKD003 | 2014 | 39 | 45 | 86.7% | |
| CKD003 | 2015 | 37 | 41 | 90.2% | |
| NM84 | 2016 | 34 | 47 | 72.3% | |
| NM84 | 2017 | 34 | 49 | 69.4% | |
| NM84 | 2018 | 35 | 48 | 72.9% | |
| NM84 | 2019 | 22 | 29 | 75.9% | |
| NM84 | 2020 | 24 | 28 | 85.7% | |
| NM84 | 2022 | 19 | 25 | 76.0% | |
| NM84 | 2023 | 18 | 21 | 85.7% |
